Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DU04SO
|
|||
| Drug Name |
RGN-352
|
|||
| Synonyms |
Thymosin Beta 4 (injectable)
Click to Show/Hide
|
|||
| Drug Type |
Peptide
|
|||
| Indication | Acute myocardial infarction [ICD-11: BA41] | Phase 2 | [1] | |
| Myocardial infarction [ICD-11: BA41-BA43] | Phase 2 | [1] | ||
| Peripheral neuropathy [ICD-11: 8C0Z] | Phase 1 | [2] | ||
| Stroke [ICD-11: 8B20; ICD-10: I64] | Phase 1 | [2], [3] | ||
| Company |
RegeneRx Biopharmaceuticals
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01311518) A Study of the Safety and Efficacy of Injectable Thymosin Beta 4 for Treating Acute Myocardial Infarction. U.S. National Institutes of Health. | |||
| REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 3 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.